10月30日港股医药ETF（159718）份额增加100.00万份

Core Viewpoint - The Hong Kong pharmaceutical ETF (159718) experienced a decline of 2.65% on October 30, with a trading volume of 47.8497 million yuan [1] Group 1: Fund Performance - The ETF's total shares increased by 1 million, bringing the total to 239 million shares [1] - The latest net asset value is calculated at 229 million yuan [1] - Since its inception on December 16, 2021, the fund has returned -4.18%, with a one-month return of -12.27% [1] Group 2: Management and Benchmark - The ETF is managed by Ping An Fund Management Co., Ltd., with the fund manager being Weng Xin [1] - The performance benchmark for the ETF is the CSI Hong Kong Stock Connect Pharmaceutical and Health Comprehensive Index (adjusted for exchange rates) [1]